Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.79 |
| ▸ | NAAA | Q02083 | 1/20 | 0.72 |
| ▸ | HTR2C | P28335 | 1/20 | 0.67 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.64 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.64 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.64 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.63 |
| ▸ | RAD52 | P43351 | 1/20 | 0.60 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.60 |
| ▸ | PAM | P19021 | 2/20 | 0.59 |
| ▸ | FAAH | O00519 | 1/20 | 0.58 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3398765 | 1.00 | DGKA (0.79) | DGKANAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL21044642 | 1.00 | DGKA (0.79) | DGKANAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL970882 | 1.00 | DGKA (0.79) | DGKANAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL128125 | 1.00 | DGKA (0.79) | DGKANAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL21044679 | 1.00 | DGKA (0.79) | DGKANAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL21044666 | 1.00 | DGKA (0.79) | DGKANAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL15635677 | 1.00 | DGKA (0.79) | DGKANAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL890025 | 1.00 | DGKA (0.79) | DGKANAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL3855552 | 1.00 | DGKA (0.79) | DGKANAAAHTR2CPRSS1PRSS2 | |
| SCHEMBL5205215 | 1.00 | DGKA (0.79) | DGKANAAAHTR2CPRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115667599-B | Heat storage composition | 住友化学株式会社 | 2026-05-12 | — | — | CN | disclosed |
| WO-2025126887-A1 | ARTICLE HAVING HEAT STORAGE PERFORMANCE | 住友化学株式会社 | 2025-06-19 | — | — | WO | disclosed |
| EP-3492526-B1 | RESIN COMPOSITION AND USE THEREOF | SUMITOMO CHEMICAL CO (JP) | 2025-02-19 | — | — | EP | disclosed |
| EP-4342958-A1 | HEAT STORAGE COMPOSITION | Sumitomo Chemical Company Limited (JP) | 2024-03-27 | — | — | EP | disclosed |
| EP-4159903-A1 | HEAT STORAGE COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-04-05 | — | — | EP | disclosed |
| CN-111164179-B | Gel compositions comprising phase change materials | 禾大国际股份公开有限公司 | 2022-04-19 | — | — | CN | disclosed |
| CN-111647975-A | Novel spandex oil agent and spandex obtained through treatment of novel spandex oil agent | 烟台锐泽化学品有限公司 | 2020-09-11 | — | — | CN | disclosed |
| CN-111164179-A | Gel compositions comprising phase change materials | 禾大国际股份公开有限公司 | 2020-05-15 | — | — | CN | disclosed |
| US-20190270923-A1 | RESIN COMPOSITION AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2019-09-05 | — | — | US | disclosed |
| EP-3492526-A1 | RESIN COMPOSITION AND USE THEREOF | Sumitomo Chemical Company Limited (JP) | 2019-06-05 | — | — | EP | disclosed |
| US-20120009222-A1 | MODULATION OF THE IMMUNE RESPONSE | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120009222-A1 | MODULATION OF THE IMMUNE RESPONSE | FCGRT, MYD88, C3AR1 | DGKA 1291/4885NAAA 789/4885HTR2C 978/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.